Markets
← Back to Stocks
CAH
CARDINAL HEALTH INC
Health Care · Health Care Distributors
$210.90
-0.32%
Vol: 0.0M
Araverus Market Read
Thursday, March 19, 2026
Cardinal Health raises FY2026 profit guidance to $10+ per share, exceeding prior $9.65-$9.85 range by 7-14%
Cardinal Health raised its 2026 adjusted profit guidance to at least $10 per share, representing 7-14% upside from the prior range of $9.65 to $9.85, reflecting confidence in pharmaceutical distribution and specialty pharmacy growth. The stock closed at $212.45 yesterday, declined $1.01 in regular trading, then recovered $0.25 in after-hours, showing constructive momentum into the raise. 13 analysts rate CAH as Buy with an average price target of $249.27, suggesting 17% upside from current levels.
Price 50d 200d
Previous Market Reads
2 of 2 daysSector Peers
| Company | Price | Day | 1M | Fwd P/E | Beta | Mkt Cap |
|---|---|---|---|---|---|---|
| LLYELI | $916.83 | -0.13% | -11.4% | 21.8x | 0.43 | $821.2B |
| JNJJOHNSON | $237.56 | +0.16% | -1.8% | 18.9x | 0.33 | $572.6B |
| ABBVABBVIE | $206.31 | -0.97% | -11.4% | 12.8x | 0.33 | $364.6B |
| MRKMERCK | $114.17 | -0.29% | -5.4% | 11.7x | 0.26 | $282.3B |
| UNHUNITEDHEALTH | $280.37 | -1.29% | -2.2% | 14.1x | 0.38 | $254.5B |
| AMGNAMGEN | $349.90 | -0.42% | -6.3% | 15.0x | 0.42 | $188.6B |
| ABTABBOTT | $107.19 | -1.12% | -4.5% | 17.2x | 0.74 | $186.3B |
| GILDGILEAD | $141.06 | -0.17% | -8.6% | 14.7x | 0.37 | $175.2B |
| TMOTHERMO | $470.21 | +1.18% | -6.2% | 17.5x | 0.97 | $174.7B |
Fundamentals
Market Cap$49.6B
P/E (TTM)30.4
Forward P/E18.2
Beta0.62
Div Yield96.00%
Prev Close$211.57
RSI (14-Day)
27Oversold
0305070100
52-Week Range
$120.72$210.90$233.60
From High-9.7%
From Low+74.7%
Moving Averages
50d SMA
$217.03-2.8%
200d SMA
$181.69+16.1%
Price between 50d and 200d. Testing 50d support.
Returns
1W
-3.7%
1M
-6.3%
3M
+6.8%
6M
+42.7%
1Y
+62.4%
YTD
+2.5%
Volume
Today45K
20d Avg1.7M
Ratio0.03x